Rituximab, Obinutuzumab, and Ofatumumab in CLL

Описание к видео Rituximab, Obinutuzumab, and Ofatumumab in CLL

In this segment, Myron Czuczman, MD, outlines the different roles of the various monoclonal antibodies used in the treatment of chronic lymphocytic leukemia (CLL).

Комментарии

Информация по комментариям в разработке